What are driving factors of Embolic Protection Devices Market | Top players - Abbott Laboratories, Allium Medica, Boston Scientific, Cardinal Health, Contego Medical, Edwards Lifesciences, Gore Medical, Innovative Cardiovascular Solutions, Keystone Heart,

The rising occurrence of cardiovascular diseases, particularly among elders, is a major driving force for increasing embolic protection devices market statistics. These components are prominently used in cardiac surgeries to reduce complications due to debris, owing to their superior design. Indeed, these devices also find extensive usage in ventricular assist device explantation and high-risk coronary artery bypass grafting.

End-users seeking consistent product assurance via FDA approvals

Driven by the nature of seriousness of these procedures, hospitals mandatorily prefer official FDA-approved EPD devices – a trend that is encouraging core players to constantly improve their product portfolios and bring about a change in embolic protection devices market statistics. Recently in 2017, the U.S. based Claret Medical received clearance for its Sentinel Cerebral Protection System. With the development of this system, it has set a high standard of care in the United States to protect patient from strokes.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2417

Apparently, this system has the capability to remove the debris associated with TAVR (transcatheter aortic heart valve replacement). As per statistics, the implementation of this novel system in TAVR has protected over 5,500 patients from the risk of stroke. In alignment with Claret, numerous other giants in embolic protection devices industry have been increasingly involved in the development of clinically advanced and next-generation minimally invasive medical devices.

Companies expanding their regional presence

An inherent vertical of the healthcare space, the competitive landscape of embolic protection devices market is defined by geographical expansions and M&As. Recently for instance, InspireMD, Inc., one of the global producers of embolic protection devices, signed an agreement with various regional distributors for extending its presence across myriad geographies.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2417

In Greece, the firm partnered with T-Vascular IKE Medical Supplies and in the Caribbean, it has collaborated with SRL and Endo-Serv. With this exclusive distribution agreement, InspireMD is looking forward to attracting more customers for supplying highly advanced and minimally invasive medical devices.

Another factor that may support the embolic protection devices industry player in its endeavor is that its regional distributors encompass a loyal, strong consumer base. Indeed, with companies continually adopting such tactics, embolic protection devices market statistics are likely to demonstrate an incline in the years ahead.

Companies participating vigorously in clinical trials

Apart from product differentiation, considering the future scope of highly advanced EPDs, companies in embolic protection devices industry have also been involved in the clinical trials of medical devices. The major concerns for these firms presently is safety and feasibility associated with the products. Recently, Contego Medical, LLC, a leading producer of medical devices for peripheral vascular and cardiovascular treatments, commenced a clinical trial for one of its drugs.

The trial was conducted to evaluate the safety of the Neuroguard IEP® 3-in-1 Carotid Stent & Post-Dilation Balloon System with an Integrated Embolic Protection. With this development, Contego Medical has indeed added value to its neurovascular product portfolio and its research spectrum, encouraging other embolic protection devices industry biggies to do the same.

Numerous behemoths across embolic protection devices market have been aiming to set up novel benchmarks with regards to innovative product development. For instance, recently in 2017, Venus Medtech received the official approval from the China FDA for its Venus A-valve device. Apparently, this device offers a less invasive treatment solution for patients classified under the high-risk category.

Medical device manufacturers thus, have lately been shifting their focus toward the development of highly advanced EPDs. Aided by their significant efforts, in conjunction with the emerging application arenas of these components, like atherectomy procedures, embolic protection devices industry statistics are likely to showcase a major change by 2025.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.